Biora Therapeutics Inc (BIOR) Return on Assets ROA from the second quarter of 2026 to second quarter of 2023 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biora Therapeutics Inc   (NASDAQ: BIOR)


Biora Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Biora Therapeutics Inc 's ROA in the second quarter of 2026?
Biora Therapeutics Inc recorded a cumulative net loss of $-33 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -85.79%.

However, within the Healthcare sector 1034 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from 5227 to 5821.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change 231.28 % -56.77 % -64.43 % -55.56 % -42.66 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -33 -32 -87 -111 -124
Return On Assets (TTM) -85.79 % -147.84 % -331.81 % -325.7 % -301.07 %
BIOR's Total Ranking # 5821 # 5227 # 5019 # 4937 # 5536
Total Assets (TTM) in million 100 15 18 23 30
Seq. Total Assets Change 592.01 % -17.31 % -23.7 % -24.12 % -9.7 %
Seq. Net Income Change - - - - -

BIOR's 5 Years Annual ROA >> Back to BIOR Management Effectiveness >> Compare BIOR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 499
Sector # 1035
Overall # 5488

Return On Assets Statistics
High Average Low
-12.2 %
-253.95 %
-1350.78 %
(Dec 31 2020)   (Jun 30 2014)





Financial Statements
Biora Therapeutics Inc 's Assets $ 100 million BIOR's Balance sheet
Biora Therapeutics Inc 's Income $ -17 million Quarterly BIOR's Income Statement
BIOR's Income by Division See BIOR's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change -42.66 % -51.45 % -29.53 % 1278.47 % -
Total Assets in million 30 53 109 154 11
Y / Y Net Income Change - - - - -
Net Income in million -124 -38 -247 -192 -6
Annual Return On Assets -409.63 % -72.21 % -227.32 % -124.49 % -53.58 %

BIOR's 5 Years Annual ROA >> Back to BIOR Management Effectiveness >> Compare BIOR ROA to its Competitors



More Return On Assets Ratios
BIOR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BIOR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BIOR's Competitors
Subscribers only: Roa for Biora Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for BIOR's Customers

You may also want to know
BIOR's Roi BIOR's Inventory Turnover Ratio BIOR's Growth Rates BIOR's Dividend Comparisons
BIOR's Profitability Ratios BIOR's Asset Turnover Ratio BIOR's Dividend Growth
BIOR's Roe BIOR's Valuation Ratios BIOR's Financial Strength Ratios BIOR's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-08-30T01:16:03+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.